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Abstract
Sepsis-induced immunosuppression increases the risk of chronic infection and reduces survival. Myeloid-derived
suppressor cells (MDSCs) expand in the bone marrow and spleen during murine polymicrobial sepsis, contributing to
immunosuppression. A better understanding of molecular controls of MDSC production is needed to identify treatment
targets. We previously reported that miR-21 and miR-181b couple with transcription factor NFI-A to induce MDSCs
during murine sepsis. Here, we expand upon these observations by showing that conditional deletion of the Nfia gene in
the myeloid lineage precludes MDSC development. NFI-A-deficient Gr1+CD11b+ myeloid cells are not immunosuppressive and differentiate normally into macrophages and dendritic cells. In contrast, ectopically expressed NFI-A prevents
differentiation of these immature Gr1+CD11b+ cells, while converting them into MDSCs. In addition, NFI-A-deficient
Gr1+CD11b+ cells decreased, and cells transfected with NFI-A increase expression of miR-21 and miR181b. Our results
support a myeloid cell loop in which NFI-A and miR-21 and miR-181b sustain Gr1+CD11b+ MDSC-dependent immunosuppression during sepsis.
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Introduction
Myeloid-derived suppressor cells (MDSCs) are
generated during infection with systemic inﬂammation
in animals and humans.1,2 Although phenotypically
similar to the immature myeloid cells that are generated
under normal conditions, MDSC cannot diﬀerentiate
into mature innate immune cells.3,4 Mouse MDSCs
are phenotyped by the same myeloid cell surface markers, Gr1 and CD11b, as found on normal immature
myeloid cells.5 However, MDSCs repress both innate
and adaptive immune responses by producing immunosuppressive mediators, such as IL-10 and TGF-b.3,6
Because infection and inﬂammation promote
Gr1+CD11b+ MDSC expansion, they appear to be
pathologically activated immature myeloid cells.7 In
addition, myeloid progenitor pool expansion into
Gr1+CD11b+ MDSCs comes at the expense of the
eﬀector innate immune cells. We and others have previously reported dramatic increases in the number of

Gr1+CD11b+ MDSCs in the bone marrow and
spleens of mice during polymicrobial sepsis.8,9 This
becomes increasingly prominent during the late/chronic
phase of sepsis,8 during which time immunosuppression
correlates with increased mortality rates.8 Because
Gr1+CD11b+ myeloid progenitors are generated as
the immune system needs to repopulate lost immune
cells, their expansion and re-programming into
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MDSCs may result from dysregulated or ‘emergency’
myelopoiesis.1,10
The transcription factor NFI-A has been implicated
in regulation of myeloid cell diﬀerentiation, since it supports the undiﬀerentiated state.11–13 Overexpression of
NFI-A in human myeloid progenitor cells attenuates
monocytic and granulocytic diﬀerentiation.12,14 We
reported that NFI-A expression is induced during
murine sepsis, and that Gr1+CD11b+ MDSCs from
septic mice have high levels of NFI-A protein.15 Our
previous loss- and gain-of-function studies revealed
that NFI-A promotes Gr1+CD11b+ MDSC expansion
during sepsis.15,16 We further showed that NFI-A
knockdown in Gr1+CD11b+ MDSCs facilitates their
diﬀerentiation and maturation to macrophages and
dendritic cells, whereas its overexpression in
Gr1+CD11b+ immature myeloid progenitors from
naive mice switches them into the Gr1+CD11b+
MDSC phenotype.15 Those studies also revealed that
NFI-A promotes late/chronic immunosuppression,
which aﬀects sepsis mortality in animals and
humans.17–21
To further support our previous studies and probe
the mechanisms by which NFI-A induces and sustains
Gr1+CD11b+ MDSCs, we generated a mouse model
with conditional, myeloid cell-speciﬁc deletion of the
Nﬁa allele, where Nﬁa expression is inactivated only
in the myeloid lineage. These mice have no gross
phenotypic abnormalities and have a normal myeloid
cell repertoire. Here, we show that NFI-A-deﬁcient
myeloid progenitors do not generate Gr1+CD11b+
MDSCs and diﬀerentiate normally during murine
sepsis. We identify a loop between NFI-A and miR-21
and miR-181b that sustains Gr1+CD11b+ MDSC
generation and limits diﬀerentiation of monocytes
and dendritic cells. We further show that NFI-A
decreases growth factor receptors that support
normal myeloid diﬀerentiation. Findings from
this study further endorse molecular targeting of
Gr1+CD11b+ MDSC generation as potential treatment for prolonged sepsis immunosuppression.

Materials and methods
Mice
Generation of BALB/c Nﬁa conditional, myeloid cellspeciﬁc knockout mice has been described previously.22
The Nﬁaﬂox/ﬂox;Lyz2Cre/+ mice, where the expression of
the Cre recombinase inactivates the ﬂoxed Nﬁa allele in
the myeloid lineage cells, served as our myeloid-speciﬁc
knockout. The Nﬁaﬂox/ﬂox;Lyz2+/+ mice, which do not
express the Cre recombinase and thus the ﬂoxed Nﬁa
allele is still expressed in the myeloid lineage cells,
served as controls. The mice were bred and housed in
a pathogen-free facility in the Division of Laboratory
Animal Resources. Male mice, 8–10 wk old, were used
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in this study. All experiments were conducted in
accordance with National Institutes of Health guidelines and were approved by the East Tennessee State
University Animal Care and Use Committee.

Polymicrobial sepsis
Polymicrobial sepsis was induced by cecal ligation and
puncture (CLP) using a 23-G needle as described previously.23 Mice received (i.p.) 1 ml lactated Ringers
solution plus 5% dextrose for ﬂuid resuscitation.
This model creates a prolonged infection with
100% mortality over 4 wk. To generate late sepsis,
mice were subcutaneously administered antibiotic (imipenem; 25 mg/kg body mass) or an equivalent volume
of 0.9% saline. To establish intra-abdominal infection
and approximate the clinical situation of early human
sepsis where there often is a delay between the onset
of sepsis and the delivery of therapy,24 injections of
imipenem were given at 8 and 16 h after CLP, which
results in high mortality (70%) during the late/
chronic phase, i.e., the time after d 5 of sepsis
induction.23

Gr1+CD11b+ cells
Gr1+CD11b+ cells were isolated from the bone
marrow by use of magnetically assisted cell sorting
according to the manufacturer’s protocol (Miltenyi
Biotech, Auburn, CA, USA). The bone marrow cells
were ﬂushed out of the femurs with RPMI-1640
medium (without serum) under aseptic conditions.23
A single cell suspension of the bone marrow was
made by pipetting up and down and ﬁltering
through a 70-mm nylon strainer, followed by incubation
with erythrocyte lysis buﬀer. After washing, total
Gr1+CD11b+ cells were puriﬁed by subjecting the
single cell suspension to positive selection of the
Gr1+CD11b+ cells by incubating with biotin-coupled
mouse anti-Gr1 Ab (Clone RB6-8C5; eBioscience,
San Diego, CA, USA) for 15 min at 4 ºC. Cells were
then incubated with anti-biotin magnetic beads for
20 min at 4 ºC and subsequently passed over a MS
column. Puriﬁed Gr1+CD11b+ cells were then
washed and resuspended in sterile saline. The cell
purity was determined by ﬂow cytometry and was typically 90%.
Gr1+CD11b+ cells were cultured in RPMI-1640
medium (Invitrogen, Carlsbad, CA, USA) supplemented with 100 U/ml penicillin, 100 mg/ml streptomycin, 2 mM L-glutamine (all from Hyclone
Laboratories, Logan, UT, USA) and 10% FBS
(Atlanta Biologicals, Lawrenceville, GA, USA) at
37 C and 5% CO2. In some experiments, cells were
stimulated for 12 h with 1 mg/ml of LPS, and culture
supernatants were used for cytokine measurements by
ELISA.
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Gr1+CD11b+ cells differentiation
Gr1+CD11b+ cells were cultured for 6 d with complete
RPMI 1640 medium in the presence of 10 ng/ml of
M-CSF (PeproTech, Rocky Hill, NJ, USA) and
10 ng/ml rIL-4 (eBioscience). The cell phenotypes
were analyzed by ﬂow cytometry.

Flow cytometry
Cells were labeled by incubation for 30 min on ice in
staining buﬀer (PBS plus 2% FBS) with the appropriate
ﬂuorochrome-conjugated Abs. After washing, the samples were analyzed by a FACSCaliber ﬂow cytometer
(BD Biosciences, Sparks, MD, USA). About 25,000
events were acquired and analyzed using the
CellQuest Pro software (BD Biosciences). The following Abs were used: anti-Gr1 conjugated to FITC, antiCD11b conjugated to phycoerythrin (PE), anti-F4/80
conjugated to allophycocyanin, anti-CD11c conjugated
to PE, anti-MHC II conjugated to FITC and anti-CD4
conjugated to PE. An appropriate isotype-matched
control was used for each Ab.

NFI-A expression construct
Full length mouse Nﬁa cDNA was cloned in a pEZM07 plasmid expression vector downstream of the
CMV promoter, and NFI-A protein expression was
veriﬁed by Western blot. An empty pEZ-M07 vector
served as a negative control.

Gr1+CD11b+ cell transfection
For NFI-A transfection, plasmid DNA was suspended
in HiPerFect reagent at a 0.5 mg/ml ﬁnal concentration
(Qiagen, Valencia, CA, USA). For Rb knockdown,
pools of Rb-speciﬁc or scrambled (control) siRNAs
were suspended in HiPerFect reagent at a 0.5 mM ﬁnal
concentration. Cells were transfected using the Gene
Pulser MXCell system (Bio-Rad, Hercules, CA,
USA). After 24 h, cells were diﬀerentiated for 6 d with
M-CSF plus rIL-4. In some experiments, diﬀerentiated
cells were stimulated for 12 h with Gram-negative bacterial LPS (Escherichia coli serotype 0111:B4; SigmaAldrich, St. Louis, MO, USA). Cell viability was
assessed by a MTT Cell Viability Assay Kit (Biotium,
Fremont, CA, USA).

CD4+ T cell proliferation assay
A co-culture of CD4+ T cells and Gr1+CD11b+ cells
was used to determine the suppressive eﬀect of
Gr1+CD11b+ cells on T-cell proliferation. Brieﬂy,
spleen CD4+ T cells were isolated from normal
(naive) mice by positive selection using magnetic
beads (Miltenyi Biotech). Cells were ﬂuorescently
labeled with carboxy-ﬂuorosceindiacetate, succinimidyl
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ester (CFSE) dye using the Vybrant CFDA SE Cell
Tacer Kit (Invitrogen Molecular Probes, Eugene, OR,
USA). Cells were incubated for 10 min at room temperature (20–25  C) with 10 mM CFSE dye and then cocultured (at 1:1 ratio) with Gr1+CD11b+ cells, which
were isolated from the bone marrow of late septic mice.
T-Cell proliferation was induced by the stimulation
with an anti-CD3 plus anti-CD28 Ab (1 mg/ml/each).
After 3 d, cells were harvested and CD4+ T cell proliferation was determined by the step-wise dilution of
CFSE dye in dividing, CD3-gated CD4+ T cells using
ﬂow cytometry.

Measurement of miRNA expression
Real-time qPCR (RT-qPCR) was used to determine
levels of miR-21, miR-181b and miR-223 in control
and NFI-A-deﬁcient Gr1+CD11b+ cells. Cells were
isolated from the bone marrow of sham and septic
mice. miRNA-enriched RNA was isolated and measured using miScript SYBR Green PCR kit with
miScript Primer Assays speciﬁc to miR-21 and miR181b according to the manufacturer’s protocol
(Qiagen). The relative expression of each miRNA was
calculated using the 2–Ct cycle threshold method
after normalization to the endogenous U6 RNA as an
internal control.
For M-CSFr and G-CSFr expression, RNA
was measured using QuantiNova SYBR Green
RT-PCR kit and QuantiTect Primer Assays speciﬁc
to M-CSFr and G-CSFr (Qiagen). Sample data were
normalized to GAPDH mRNA levels and are
presented as fold change relative to RNA from
sham cells.

Western blot
Equal amounts of whole cell lysate were mixed with
5  Laemmeli sample buﬀer, separated by a SDS
10% polyacrylamide gel (Bio-Rad) and subsequently
transferred to nitrocellulose membranes (Thermo
Fisher Scientiﬁc, Waltham, MA, USA). After blocking with 5% milk in Tris-buﬀered saline/Tween-20
for 1 h at room temperature, membranes were
probed for 16 h at 4 ºC with the appropriate primary
Abs (Santa Cruz Biotechnology, Dallas, CA, USA).
After washing, blots were incubated with appropriate
HRP-conjugated secondary Ab (Life Technologies,
Grand Island, NY, USA) for 2 h at room temperature. Proteins were detected with the enhanced chemiluminescence detection system (Thermo Fisher
Scientiﬁc). The developed bands were visualized
using the ChemiDoc XRS System (Bio-Rad) and
the images were captured with the Image Lab
Software V3.0. Membranes were stripped and reprobed with b-actin Ab (Sigma-Aldrich) as a loading
control.

Dai et al.
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Cytokine levels were determined using speciﬁc ELISA
kits (eBioscience) according to the manufacturer’s
instructions. Each sample was run in duplicate.

Statistical analysis
Data are expressed as mean  SD and were analyzed by
Microsoft Excel, V3.0. Diﬀerences among groups were
analyzed by a two-tailed Student’s t-test for two groups
and by ANOVA for multiple groups. P < 0.05 was considered statistically signiﬁcant.

Results
NFI-A is responsible for the Gr1+CD11b+ MDSC
expansion during sepsis
Targeted deletion of the Nﬁa allele in the myeloid lineage
in mice improves sepsis survival by about 78%.25 In this
conditional knockout model, NFI-A expression, which
is induced following sepsis initiation,15 is disrupted only
in the myeloid lineage cells, and these mice have normal
innate and adaptive immune cell numbers.25 Because the
immunosuppressive Gr1+CD11b+ cells generated
during sepsis and the naive/normal Gr1+CD11b+ cells
are phenotypically similar, we herein refer to sepsis
Gr1+CD11b+ cells as ‘Gr1+CD11b+ MDSCs’. As
shown in Figure 1, the Gr1+CD11b+ MDSC population did not expand in NFI-A knockout mice during
sepsis. Compared with the control group, these mice
still generate normal Gr1+CD11b+ cells at rates similar
to sham mice. Thus, NFI-A drives Gr1+CD11b+
MDSC expansion during sepsis but does not aﬀect generation of normal Gr1+CD11b+ cells.

NFI-A sustains expression of miR-21 and miR-181b
during late sepsis
We have shown that the miR-21 and miR-181b are
induced in early sepsis Gr1+CD11b+ MDSCs and
are further increased during late sepsis.16 Inhibition of
miR-21 and miR-181b in vivo using antagomiRs markedly reduced Gr1+CD11b+ MDSC expansion.16 Those
studies also revealed that NFI-A is a downstream eﬀector of miR-21 and miR-181b. To further investigate the
eﬀect of the Nﬁa myeloid-speciﬁc deletion on the miR21 and miR-181b expression during sepsis, we measured their levels in the control and NFI-A conditional
knockout mice during sepsis. Expression of miR-21 and
miR-181b was induced in the Gr1+CD11b+ MDSCs in
the control mice (expressing NFI-A) during early
sepsis and was further increased during late sepsis
(Figure 2a). Importantly, expression of miR-21 and
miR-181b was diminished in the normal functioning
Gr1+CD11b+ cells in NFI-A conditional knockout
mice.

% Gr1+CD11b+ cells

ELISA
100
90
80
70
60
50
40
30
20
10
0

Control
Nfia cKO

*

*

sham

Early sepsis

Late sepsis

Figure 1. Myeloid-specific deletion of the Nfia gene attenuates
Gr1+CD11b+ cell expansion during sepsis. Sepsis was induced by
CLP using a 23-G needle, and mice were given antibiotics (imipenem) with fluid resuscitation. With this injury and treatment,
sepsis develops into an early phase (defined as d 1–5) and a late
phase (d 6 thereafter). Mice that were moribund (control group)
during early or late sepsis were subjected to euthanasia. A corresponding number of surviving, healthy-appearing mice (Nfia KO
group) were euthanized and analyzed at the same time and are
reported here as ‘‘surviving.’’ Bone marrow cells were harvested,
stained with anti-Gr1 and anti-CD11b Abs, and analyzed by flow
cytometry. Percentages of the Gr1+CD11b+ in the bone marrow
are shown. Data are expressed as mean  SD (*P < 0.05) of five
mice per group and represent one of three experiments.
*Compared with conditional knockout (cKO).

Stat3 phosphorylation and C/EBPb protein expression are induced in Gr1+CD11b+ MDSCs during
sepsis in mice, where they bind to and activate the
miR-21 and miR-181b promoters.26 We investigated
whether NFI-A deﬁciency aﬀects phosphorylated
Stat3 and/or C/EBPb protein levels in the normal
Gr1+CD11b+ cells and thus may be responsible for
the inhibition of miR-21 and miR-181b expression.
Western blot analysis showed no diﬀerences in Stat3
phosphorylation or C/EBPb protein between the control and NFI-A conditional knockout mice throughout
sepsis response (Figure 2b). These results suggest that
NFI-A may act in a feedback manner to sustain expression of miR-21 and miR-181b in the Gr1+CD11b+
MDSCs during sepsis.

NFI-A knockout reverses expression of the proteins
that support development of Gr1+CD11b+ MDSCs
The NFI-A negatively regulates p21 gene expression in
proliferating human cells.27 P21 is a cyclin-dependent
kinase (cdk) inhibitor involved in cell diﬀerentiation.28
We reported previously that NFI-A and p21 proteins
are reciprocally expressed in sepsis Gr1+CD11b+
MDSCs.15 We ﬁrst determined p21 protein levels in
the Gr1+CD11b+ cells from the control and NFI-A
conditional knockout mice. As shown in Figure 3(a),
p21 was expressed in sham Gr1+CD11b+ cells from
the control mice, where NFI-A was not expressed,
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Figure 2. Expression of miR-21 and miR-181b is lost in Gr1+CD11b+ cells from late, but not early, septic NFI-A knockout mice.
Bone marrow Gr1+CD11b+ cells were isolated from sham and septic mice. (a) miRNA-enriched RNA was isolated, and levels of miR21 and miR-181b were measured by RT-qPCR using miR-21 and miR-181b specific assay primer sets. Values were normalized to
U6 RNA as an internal control. Data are expressed as mean  SD (*P < 0.05) of five mice per group. Values from sepsis mice are
presented relative to sham values (set at onefold) and represent one of two experiments. *Compared with sham. cKO: conditional
knockout. (b) Knockout of NFI-A does not affect Stat3 phosphorylation or C/EBPb protein levels in Gr1+CD11b+ cells during sepsis.
Whole protein extracts from Gr1+CD11b+ cells were subjected to Western blotting of the indicated proteins. Lower panels show
densitometry of the Stat3 and C/EBPb protein bands. Values were normalized to b-actin and are presented relative to sham. The
results represent one of two experiments.

but sepsis induced NFI-A expression and diminished
p21 expression. In contrast, p21 expression was maintained in the Gr1+CD11b+ cells in the conditional
knockout mice during sepsis.
The cdk4 protein is induced in sepsis Gr1+CD11b+
MDSCs owing to lack of p21 and forms a protein
complex with cyclin D1, which inhibits PTEN, leading
to NF-kB activation and thus expansion of the
Gr1+CD11b+ MDSCs.15 We then investigated the
eﬀects of NFI-A conditional knockout on the expression of cyclin D1, cdk4, PTEN and NF-kB p65.
Western blot analysis showed that levels of cdk4
protein and NF-kB activation were diminished,
whereas PTEN expression was maintained in the
normal Gr1+CD11b+ cells from the NFI-A
conditional knockout mice (Figure 3b).
To test the inducing eﬀect of NFI-A on NF-kB
activation and its support of Gr1+CD11b+ MDSC
expansion, we introduced NFI-A into late sepsis
Gr1+CD11b+ cells from the NFI-A conditional
knockout mice, which are functionally normal.
Ectopic expression of NFI-A diminished p21 protein
levels and activated NF-kB (Figure 4a). Moreover, differentiation into macrophages and dendritic cells in the
presence of growth factors was reduced signiﬁcantly

compared with cells transfected with vector alone,
and was similar to Gr1+CD11b+ MDSCs from the
control mice expressing NFI-A (Figure 4b). The
decrease in cell diﬀerentiation after NFI-A transfection
was not due to increase in cell death, because cell survival analysis showed nearly equal numbers of cells in
the control and transfected cells (Figure 4c). In addition, transfection eﬃciency of Gr1+CD11b+ cells
with HiPerFect reagent using Gene Pulser system was
about 65%, as demonstrated by GFP expression
(Figure 4d). Collectively, these results support that
NFI-A induction during sepsis is suﬃcient to trigger
the molecular pathway leading to the expansion of
Gr1+CD11b+ MDSCs.

Ectopic expression of NFI-A in sepsis Gr1+CD11b+
cells from the NFI-A knockout mice reactivates
expression of miR-21 and miR-181b
Induction of miR-21 and miR-181b expression in sepsis
Gr1+CD11b+ MDSCs is mediated by Rb phosphorylation by the cyclin D1–cdk4 protein complex.26 In these
cells, phosphorylated Rb binds to and sequesters the
C/EBPa protein, leading to Stat3 and C/EBPb binding
to and activating of the miR-21 and miR-181b

Dai et al.
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Figure 3. Measurements of proteins involved in Gr1+CD11b+
cell expansion in sepsis. Gr1+CD11b+ cells were isolated from
the bone marrows of sham and septic mice (n ¼ 6 mice per
group). (a) p21 is expressed in sepsis Gr1+CD11b+ cells from
Nfia knockout mice. Gr1+CD11b+ cell extracts were prepared,
and levels of NFI-A and p21 proteins were determined by
Western blot. (b) Reversal of CDK4, PTEN and NF-kBp65 protein expression patterns in sepsis Gr1+CD11b+ cells from NFI-A
knockout mice. Levels of CDK4, PTEN and NF-kBp65 proteins in
Gr1+CD11b+ cells were determined by Western blot. The
results represent one of three experiments. cKO: conditional
knockout.

promoters.26 The Gr1+CD11b+ cells from the NFI-A
conditional knockout mice did not express miR-21 and
miR-181b (Figure 2a). To conﬁrm that NFI-A deﬁciency in Gr1+CD11b+ cells prevents miR-21 and
miR-181b expression via modulating Rb phosphorylation, we expressed NFI-A in sepsis Gr1+CD11b+
cells from the NFI-A knockout mice and determined
the miRNA levels. NFI-A induced cdk4 expression
(Figure 5a), which is required for Rb phosphorylation
as described above. Expression of cdk did not aﬀect Rb
protein levels but induced its phosphorylation. The
phosphorylation of Rb resulted in reactivation of
miR-21 and miR-181b expression (Figure 5b).
To further investigate the role of Rb phosphorylation in the induction of miR-21 and miR-181b expression, we expressed NFI-A in the sepsis, NFI-A-deﬁcient
Gr1+CD11b+ cells, in which Rb has been knocked
down with siRNAs. As shown in Figure 5(c), lack of
Rb diminished miR-21 and miR-181b expression despite the presence of ectopically expressed NFI-A protein. These results demonstrate that NFI-A sustains the
miR-21 and miR-181 expression in Gr1+CD11b+
MDSCs
during
sepsis
via
promoting
Rb
phosphorylation.

NFI-A-deficient Gr1+CD11b+ cells from septic mice
are not immunosuppressive
Gr1+CD11b+ MDSCs contribute to late sepsis
immunosuppression by producing immunosuppressive
mediators such as IL-10, and also by inhibiting T-cell
activation and proliferation.8,15 We next examined the
functional phenotypes of the Gr1+CD11b+ cells generated in the NFI-A conditional knockout mice during
sepsis. We expressed NFI-A in late sepsis
Gr1+CD11b+ cells from the NFI-A conditional
knockout mice. As expected, upon stimulation with
the Gram-negative bacterial LPS, the Gr1+CD11b+
MDSCs from control, septic mice produced signiﬁcantly lower and higher levels, respectively, of TNF-a
and IL-10 compared with cells from the NFI-A conditional knockout mice that were transfected with vector
alone (Figure 6a). The introduction of NFI-A into the
NFI-A-deﬁcient cells from septic mice diminished
TNF-a, while signiﬁcantly increasing IL-10 production
compared with the same cells that were transfected with
vector alone. When co-cultured with CD4+ T cells,
sepsis NFI-A-deﬁcient Gr1+CD11b+ cells transfected
with NFI-A plasmid signiﬁcantly inhibited T-cell proliferation compared with cells transfected with vector
alone (Figure 6b). This eﬀect was similar to the
Gr1+CD11b+ MDSCs from the control, NFI-Aexpressing
mice.
These
results
show
that
Gr1+CD11b+ cells generated during sepsis in the
absence of NFI-A are not immunosuppressive.

NFI-A diminishes expression of miR-223 and the
receptors for colony-stimulating factors
To further investigate the mechanism of the
Gr1+CD11b+ MDSC expansion by NFI-A during
sepsis, we measured expression of miR-223, as well as
the receptors for macrophage and granulocyte colonystimulating factor (M-CSFr and G-CSFr). NFI-A targets miR-223, the expression of which is increased with
myeloid cell diﬀerentiation and maturation.11 Our previous studies showed that miR-223 expression was not
increased in sepsis Gr1+CD11b+ MDSCs.16 Real-time
PCR analysis revealed that miR-223 was expressed at
very low levels in the control, NFI-A-expressing
Gr1+CD11b+ MDSCs, whereas it levels were signiﬁcantly increased in NFI-A-deﬁcient Gr1+CD11b+ cells
(Figure 7a). In addition, NFI-A down-regulates expression of M-CSF receptor and G-CSF receptor on human
hematopoietic progenitors,12,14 which attenuates their
monocytic and granulocytic diﬀerentiation, respectively. During early sepsis, expression of M-CSFr and
G-CSFr was signiﬁcantly increased, with higher levels
in the Gr1+CD11b+ MDSCs from the control compared with the Gr1+CD11b+ cells from the NFI-A
conditional knockout mice (Figure 7b). Importantly,
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Figure 4. Ectopic expression of NFI-A in Gr1+CD11b+ from septic NFI-A knockout mice attenuates their differentiation into
macrophages and dendritic cells. Gr1+CD11b+ cells were isolated from the bone marrow of late septic NFI-A conditional knockout or
control mice and transfected with an NFI-A expression plasmid or an empty vector. (a) After 36 h, portions of the cells were
harvested, cell extracts were prepared, and levels of NFI-A and p21 proteins were determined by Western blot. (b) The remainder of
the cells was differentiated for 6 d with M-CSF plus rIL-4 (10 ng/ml/each). Flow cytometry analysis of the differentiated cells gated on
F4/80+ CD11b+ or CD11c+ MHC II+ staining is shown. Data are expressed as mean  SD (*/#P < 0.05) of five mice per group and
represent one of three experiments. (c) Percentages of cell survival 36 h after transfection was determined by MTT cell viability assay.
(d) Flow cytometry dot plot showing GFP transfection efficiency in Gr1+CD11b+ cells using HiPerFect reagent and Gene Pulser. Values
are the mean  SD of three transfections. *Compared with cells from NFI-A control mice; #Compared with cells isolated from NFI-A
cKO mice and transfected with vector. cKO: conditional knockout.

both M-CSFr and G-CSFr expressions diminished
during late sepsis in Gr1+CD11b+ MDSCs from the
control mice but remained signiﬁcantly higher in the
Gr1+CD11b+ cells from NFI-A knockout mice.
Next, we measured miR-223, M-CSFr and G-CSFr
levels after introducing NFI-A expression into late
sepsis Gr1+CD11b+ cells from the NFI-A conditional
knockout mice. As shown in Figure 7(c, d), ectopic
expression of NFI-A signiﬁcantly reduced miR-223,
M-CSFr and G-CSFr expression levels (compared
with late sepsis cells in Figure 7a and b). These results
suggest that the induction of NFI-A expression in

Gr1+CD11b+ MDSCs during sepsis is responsible
for the downregulation of miR-223, M-CSFr and
G-CSFr, thereby limiting normal diﬀerentiation and
maturation of myeloid cells.

Discussion
While diﬀerent molecular pathways promote
Gr1+CD11b+ MDSC expansion under distinct pathological conditions,4,29 their immature phenotype supports the hypothesis that dysregulated myeloid cell
diﬀerentiation and maturation is responsible for their
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Figure 5. Phosphorylated Rb protein promotes the expression of miR-21 and miR-181b in Gr1+CD11b+ cells during sepsis.
Gr1+CD11b+ cells were isolated from the bone marrow of late septic NFI-A conditional knockout mice and transfected with an NFI-A
expression plasmid or an empty vector for 36 h. (a) Ectopic expression of NFI-A restores RB phosphorylation and the miRNA
expression. Levels of CDK4, Rb and p-Rb (Ser780) proteins were determined by Western blot. The results are representative of three
experiments. (b) miRNA-enriched RNA was isolated, and levels of miR-21 and miR-181b expression were measured by RT-qPCR using
miR-21 and miR-181b specific assay primer sets. Values were normalized to U6 RNA as an internal control. Data are expressed as
mean  SD (*P < 0.05) of five mice per group and represent one of two experiments. *Compared with vector. (c) Ectopic expression
of NFI-A in the absence of RB does not restore the miRNA expression. Gr1+CD11b+ cells, isolated from the bone marrows of late
septic conditional NFI-A knockout mice, were transfected with Rb-specific or scramble (control) siRNAs. After 12 h, cells were
washed and transfected with an NFI-A expression plasmid or an empty vector for 24 h. Cell extracts were prepared from portion of
the cells and used to determine Rb protein levels by Western blot. The results are representative of two Western blots. The
remainder of the cells was used to isolated miRNA-enriched RNA, and levels of miR-21 and miR-181b were analyzed by real-time PCR
as in (b). Data are expressed as mean  SD (*P < 0.05) of five mice per group and represent one of three experiments. cKO:
conditional knockout.

accumulation.1 This study uses cell-type-speciﬁc genetics to show that NFI-A controls molecular pathways
that generate Gr1+CD11b+ MDSCs during murine
sepsis. It also identiﬁes that NFI-A acts in a feedforward loop to sustain miR-21 and miR-181b expression
and perpetuates its own expression and expansion of
Gr1+CD11b+ MDSCs while disrupting normal myeloid cell diﬀerentiation. These molecular paths
enlighten how chronic immunosuppression may persist
during sepsis.
Accelerated or ‘emergency’ myelopoiesis coupled
with attenuated diﬀerentiation and maturation of myeloid cells generates and expands Gr1+CD11b+
MDSCs
during
chronic
inﬂammation
and

immunosuppression.1,4,30 We previously implicated
NFI-A expression in supporting Gr1+CD11b+
MDSC accumulation during sepsis, especially in the
late phases where immunosuppression predominates.15,16 The NFI-A myeloid cell-speciﬁc knockout
used in the current study enabled us to further investigate the molecular processes of the NFI-A-mediated
generation of Gr1+CD11b+ MDSCs in sepsis. These
mice have normal immune cell repertoire and are
immunocompetent, as demonstrated by mounting
pro-inﬂammatory immune responses similar to naive
mice upon challenge with bacterial LPS.25 Our ﬁnding
that targeted deletion of Nﬁa in the myeloid lineage
prevented generation of Gr1+CD11b+ MDSCs
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Figure 6. Ectopic expression of NFI-A in Gr1+CD11b+ from septic NFI-A knockout mice switches their phenotype into
immunosuppressive similar to those from control mice. Gr1+CD11b+ cells were isolated from the bone marrows of late septic NFI-A
knockout mice and transfected with an NFI-A expression plasmid or an empty vector for 36 h. (a) NFI-A reconstitution inhibits
TNF-a expression while inducing IL-10 expression in NFI-A conditional knockout cells. Cells (1  106) were cultured with 1 mg/ml LPS
for 12 h. Supernatants were collected and levels of TNF-a and IL-10 were determined by ELISA. Cells from wild type, septic mice
served as a control. (b) Gr1+CD11b+ NFI-A-deficient cells reconstituted with NFI-A suppress T cell proliferation. Gr1+CD11b+ cells
from late septic NFI-A conditional knockout mice were transfected with an NFI-A expression plasmid. After 36 h, Gr1+CD11b+ cells
were co-cultured (at 1:1 ratio) with spleen CD4+ T cells that have been isolated from normal (naive) mice and labeled with the
fluorescent dye CFSE for 10 min at room temperature. The culture was incubated in the presence of anti-CD3 plus anti-CD28 Abs
(1 mg/ml/each). After 3 d, CD4+ T cell proliferation was determined by the step-wise dilution of CFSE dye in dividing CD4+ T cells by
flow cytometry. Percentages of cell proliferation were calculated as follow: % cell proliferation ¼ 100  (count from T
cell + Gr1+CD11b+ cell culture/count from T cell culture). Data are expressed as mean  SD (*/#P < 0.05) of five mice per group and
represent one of three experiments. Cells from wild type septic mice serve as a control. *Compared with cells from NFI-A control
mice; #compared with cells isolated from NFI-A cKO mice and transfected with vector. cKO: conditional knockout.

without aﬀecting normal Gr1+CD11b+ cell development is particularly important. NFI-A is not involved
in the steady-state myelopoiesis that generates normal
Gr1+CD11b+ cells, but rather in the accelerated
or ‘‘emergency’’ myelopoiesis that generates Gr1+
CD11b+ MDSCs.
NFI-A promotes Gr1+CD11b+ MDSC expansion
during sepsis by interacting with protein mediators
involved
in
myeloid
cell
diﬀerentiation.15
Mechanistically, NFI-A blocks expression of the cdk
inhibitor p21, which facilitates cdk4 protein complex
formation and NF-kB control over diﬀerentiation.15
Here, we show that this pathway is reversed in
Gr1+CD11b+ cells generated during sepsis in the
NFI-A myeloid-speciﬁc knockout mice. Although
Gr1+CD11b+ myeloid cells from these mice

diﬀerentiate normally in the basal state, exogenous
expression of NFI-A reverses the path of NF-kB control over Gr1+CD11b+ cell diﬀerentiation and maturation (Figure 4). Most strikingly, exogenous expression
of NFI-A in Gr1+CD11b+ cells from mice with NFI-A
conditional deletion switches them to the immunosuppressive Gr1+CD11b+ MDSC phenotype, which is disrupted in the NFI-A conditional knockout. Thus, this
study clearly demonstrates that NFI-A induction
during murine sepsis is necessary and suﬃcient for generating and expanding Gr1+CD11b+ MDSCs.
Sepsis induces expression of miR-21 and miR-181b
in Gr1+CD11b+ MDSCs to support the initial
increase in NFI-A expression,16 and in vivo inhibition
of miR-21 and miR-181b simultaneously in septic mice
using miRNA inhibitors (antagomiRs) diminishes
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Figure 7. Effects of NFI-A knockout on the expression of miR-223, M-CSFr and G-CSFr. (a) miR-223 is expressed in late sepsis
Gr1+CD11b+ cells from NFI-A conditional knockout mice. Bone marrow Gr1+CD11b+ cells were isolated from sham, early and late
septic mice. miRNA-enriched RNA was isolated, and levels of miR-21 and miR-181b were measured by RT-qPCR. Values were
normalized to U6 RNA as an internal control. (b) Expression of M-CSFr and G-CSFr is increased in late sepsis Gr1+CD11b+ cells from
NFI-A conditional knockout mice. Portion of the late sepsis Gr1+CD11b+ cells described in (a) was used for RNA extraction and
determination of M-CSFr and G-CSFr mRNA levels by RT-qPCR. Values were normalized to GAPDH as an internal control. Data in (a)
and (b) are expressed as mean  SD (*/#P < 0.05) of five mice per group and are presented relative the values from sham mice (set at
onefold). Data represent one of two experiments. *Compared with control mice; #compared with early sepsis mice. (c) Ectopic
expression of NFI-A in late sepsis Gr1+CD11b+ cells from knockout mice abolishes miR-223 expression. Late sepsis Gr1+CD11b+
cells from NFI-A conditional knockout mice were transfected with empty vector or NFI-A expression plasmid for 36 h. RNA was
isolated, and levels of miR-223 were measured as in (a). (d) Ectopic expression of NFI-A in late sepsis Gr1+CD11b+ cells from
knockout mice inhibits M-CSFr and G-CSFr. Portion of the late sepsis Gr1+CD11b+ cells described in (c) was used to determine
M-CSFr and G-CSFr mRNA levels by RT-qPCR as in (b). Data in (c) and (d) are expressed as mean  SD (*P < 0.05) of five mice per
group and are presented relative the values from control, sham mice as in (a) and (b) (set at onefold). Data represent one of two
experiments. *Compared with vector. cKO: conditional knockout; r: receptor.

NFI-A expression and limits Gr1+CD11b+ MDSC
generation. Surprisingly, the current study supports
that miR-21 and miR-181b expression is lost in the
NFI-A conditional knockout mice during sepsis and
restored with genetic knock-in conditions (Figures 2
and 5). C/EBPb and Stat3 phosphorylation are induced
in sepsis Gr1+CD11b+ MDSC, where they activate
miR-21 and miR-181b promoters and expression
levels required for initial NFI-A induction.26 Here, we
found that C/EBPb protein levels and Stat3 phosphorylation in the sepsis Gr1+CD11b+ cells from NFI-A
conditional knockout mice simulate levels from the
cells obtained from control mice that express miR-21
and miR-181b. The activation of miR-21 and miR-181b

expression by C/EBPb and Stat3 is regulated by phosphorylation of the Rb protein, which is induced by
cdk4 downstream of NFI-A.26 In this study, Rb was
not phosphorylated in Gr1+CD11b+ cells from the
NFI-A conditional knockout mice during sepsis,
owing to lack of cdk4, thus providing a plausible
explanation for reduced miR-21 and miR-181b
expression. In contrast, exogenous expression of
NFI-A increased cdk4 expression and Rb phosphorylation, and reactivated miR-21 and miR-181b
expression (Figure 5). A role of NFI-A coupled
loop to miR-21 and miR-181b was conﬁrmed by
the simultaneous knockdown of Rb and the
expression of NFI-A in NFI-A-deﬁcient cells, which
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diminished the two miRNAs despite the presence of
NFI-A.
Our studies showed that miR-21 and miR-181b play
an anti-inﬂammatory/immunosuppressive role in the
later phases of sepsis-induced immunosuppression.8,16
Although both miRNAs increase during the early/proinﬂammatory sepsis phase, antagomir blockage only
aﬀected the late/anti-inﬂammatory phenotype.15,16
These ﬁndings suggest that miR-21 and miR-181b
may combine with other mediators during the late
sepsis phase to exert their anti-inﬂammatory and
immune repressor eﬀect. Other studies have also
described anti-inﬂammatory roles of miR-21 and
miR-181b under diﬀerent conditions.31,32 Barnett
et al.31 reported miR-21 deﬁciency increases mortality
in a mouse model of LPS-induced peritonitis. They also
found that miR-21 attenuated production of
pro-inﬂammatory cytokines TNF-a and IL-6 in LPSstimulated peritoneal macrophages and reduced activation of the NF-kB p65 protein in bone marrow-derived
macrophages. In contrast, miR-21 has been shown to
promote inﬂammation in diseases associated with
chronic inﬂammation such as colitis and type 2 diabetes, as well as in some cancer models where it promotes NF-kB activation in non-hematopoietic cells.33
This dual role of miR-21 may be inﬂuenced by the cell
type aﬀected and the inducing signal.33 Moreover,
in vivo administration of miR-181b can attenuate vascular inﬂammation in a mouse model of endotoxemia
via limiting NF-kB signaling, leukocyte inﬂux and lung
injury.32 These diﬀerences emphasize re-programming
sepsis inﬂammation distinctly diﬀers from pathways
that may drive chronic inﬂammation.
We also found that M-CSFr and G-CSFr signiﬁcantly increase during sepsis in the NFI-A conditional
myeloid speciﬁc knockout mice (Figure 7). This shows
that NFI-A induction and Gr1+CD11b+ MDSC
increases are concomitant with attenuation of normal
diﬀerentiation of myeloid precursors. Moreover, we
show here that NFI-A attenuates Gr1+CD11b+ cell
diﬀerentiation during sepsis by limiting miR-223,
M-CSFr and G-CSFr expression. This is compatible
with the concept that resistance mechanisms reciprocally give way to tolerance mechanisms, which may
underlie profound immunosuppression associated
with many septic deaths.
In summary, NFI-A access a key checkpoint to promote Gr1+CD11b+ MDSC generation and concomitantly limit growth factor dependent diﬀerentiation of
normal myeloid monocytes and dendritic cells needed
for competent innate and adaptive immunity.
Moreover, sustained NFI-A expression continues to
drive Gr1+CD11b+ MDSC repressor cells during
chronic sepsis, and likely underlying continued high
mortality. Targeting NFI-A may provide a novelist
treatment approach for restoring competent immunity
during the more chronic stage of sepsis.
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